|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/08/22 BioLife4D Corp. S-1/A 9/07/22 16:3.4M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: S-1/A Pre-Effective Amendment to Registration Statement HTML 1.81M
(General Form)
2: EX-1.1 Underwriting Agreement or Conflict Minerals Report HTML 315K
3: EX-3.3 Articles of Incorporation/Organization or Bylaws HTML 12K
4: EX-4.1 Instrument Defining the Rights of Security Holders HTML 106K
5: EX-4.2 Instrument Defining the Rights of Security Holders HTML 110K
6: EX-4.3 Instrument Defining the Rights of Security Holders HTML 198K
7: EX-4.4 Instrument Defining the Rights of Security Holders HTML 110K
8: EX-4.5 Instrument Defining the Rights of Security Holders HTML 133K
9: EX-4.6 Instrument Defining the Rights of Security Holders HTML 182K
10: EX-10.43 Material Contract HTML 31K
11: EX-10.44 Material Contract HTML 112K
12: EX-10.45 Material Contract HTML 103K
13: EX-10.46 Material Contract HTML 107K
14: EX-23.1 Consent of Expert or Counsel HTML 8K
15: EX-99.2 Miscellaneous Exhibit HTML 31K
16: EX-99.3 Miscellaneous Exhibit HTML 28K
Exhibit 99.3
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER
OF BIOLIFE4D CORPORATION
I. PURPOSE
The Nominating and Corporate Governance Committee (the “Committee”) of BioLife4D Corporation (the “Company”) is responsible for providing leadership with respect to the corporate governance of the Company and advising and making recommendations to the Board of Directors (the “Board”) regarding candidates for election as directors of the Company.
II. MEMBERSHIP
The Committee shall consist of at least three members, each of whom shall meet the independence requirements of the stock exchanges on which the Company’s common stock is listed or approved for quotation and applicable laws.
The Committee’s membership may follow phase in provisions of the applicable stock exchanges, so that the Committee shall initially have one independent director; a majority of independent committee members within 90 days of the effective date of the Company’s initial public offering (“IPO”) registration statement; and all independent members within one year of the IPO registration statement effective date.
The Chairperson and members of the Committee shall be appointed, annually for a term of one year or until their successors are duly appointed and qualified by the Board. The Board shall appoint a new member or members in the event of a vacancy on the Committee that reduces the number of members below three, or in the event that the Board determines that the number of members on the Committee should be increased. The Board may remove any member of the Committee with or without cause at any time.
III. MEETINGS
The Committee shall meet in person at least once a year, and may hold additional meetings in person or telephonically or other similar communications equipment, as often as may be necessary or appropriate, in the discretion of the Chairperson of the Committee. The Chairperson of the Committee, to the extent feasible, will circulate or discuss the agenda for the meeting in advance with each member of the Committee.
The Chairperson of the Committee may also request that members of management, legal counsel, or other advisors attend the meetings of the Committee.
IV. COMMITTEE RESPONSIBILITIES AND AUTHORITY
The specific responsibilities of the Committee shall include, but are not limited to, the following:
1. Develop recommendations to the Board as to the skills and qualifications required of directors and other criteria to be considered in selecting potential candidates for Board membership.
C:
| C: 1 |
2. Identify recruits and screen candidates for future Board membership.
3. Annually evaluate candidates to be nominated to serve on the Board and recommend the slate of nominees for election at the annual meeting of shareholders and to fill vacancies or new positions on the Board, as necessary or advisable.
4. Establish procedures for consideration of, and consider any nominations of, director candidates validly made by the shareholders in accordance with applicable laws, rules, or regulations and for recommendation to the Board.
5. Review and recommend to the Board, retirement and other tenure policies for directors.
6. Review and make recommendations to the Board with respect to proposals properly presented by shareholders for inclusion in the Company’s annual proxy statement. The Committee may, as appropriate in light of the proposal’s subject matter, refer any proposal to any other committee of the Board for purposes of review and recommendations.
7. Annually recommend to the Board for approval the appointment of directors to Board committees and the selection of a Chairperson for each Board committee. Annually evaluate existing board member performance and effectiveness. Review and make recommendations to the Board concerning any removal of committee members.
8. Annually recommend to the other independent directors for their selection the independent director who will preside at all meetings of the independent directors and exercise such other responsibilities as may be determined by a majority of the independent directors.
9. Annually review the Company’s corporate governance principles and practices in light of changing conditions and shareholders’ interests and make recommendations to the Board regarding appropriate modifications.
10. Annually evaluate the overall effectiveness of the organization of the Board (including the effectiveness of the committee structure) and the Board’s (and committees’) effectiveness in the performance of its governance responsibilities and report such findings to the Board.
11. Adopt and implement a policy or policies, as appropriate, governing service on the Board of other companies, charities, and institutions applicable to members of the Board and executive officers of the Company.
12. Annually review the Company’s corporate charitable and political contributions and expenditures to ensure alignment with Company policies and values.
13. Annually review and assess the effectiveness of the Company’s environmental and social responsibility policies, goals, and programs and make recommendations as deemed appropriate based on such review and assessment.
14. Review the Company’s succession plans for the CEO and other executive officers and update or revise such plans as appropriate.
15. Review the adequacy of this Charter annually, or more often as circumstances dictate, and update or revise the Charter as appropriate.
C:
| 2 |
16. Annually evaluate and take steps to improve the effectiveness of the Committee in meeting its responsibilities under this Charter.
17. The Committee shall have the authority in the performance of its responsibilities to:
| a. | Retain, at the Company’s expense, and terminate any search firm or firms to be used to identify director candidates and authority to approve any such firm’s fees and other retention terms; and | |
| b. | Retain, at the Company’s expense, legal counsel, accounting, or other advisors as appropriate to assist in the performance of its duties hereunder, and approve the fees and other retention terms of such advisors. |
V. OPERATIONS
The Committee shall meet as often as it deems desirable. The Committee shall take written minutes of its meetings and activities and circulate it to each member of the Committee and to the full Board. The Committee shall submit such minutes to the recording secretary of the Company for filing. The Chairperson of the Committee shall report to the Board as requested by the Chairman of the Board.
The Committee shall be governed by the same rules regarding meetings (including meetings in person or by telephone or other similar communications equipment), action without meetings, notice, waiver of notice, and quorum and voting requirements as are applicable to the Board.
The Committee may invite such members of management to its meetings as it deems appropriate. However, the Committee shall meet regularly without such members present (including employee members of the Committee), and such management members shall not be present at meetings at which their nomination or performance is discussed or determined or under circumstances when the independence of Committee determinations may be compromised.
VI. DELEGATION OF AUTHORITY
The Committee shall have the authority to delegate any of its responsibilities, along with the authority to take action in relation to such responsibilities, to one or more subcommittees as the Committee may deem appropriate in its sole discretion.
VII. PERFORMANCE EVALUATION
The Committee shall perform a periodic review and evaluation of the performance of the Committee and its members, including the compliance of the Committee with this Charter. In addition, the Committee shall review and reassess periodically the adequacy of this Charter and recommend to the Board any improvements to this Charter that the Committee considers necessary or desirable. The Committee shall conduct such evaluations and reviews in such manner, and at such times, as it deems appropriate.
C:
| 3 |
| This ‘S-1/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 9/8/22 | None on these Dates | ||
| Filed on: | 9/7/22 | |||
| 8/23/22 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/05/23 BioLife4D Corp. 1-SA 6/30/23 3:2.5M Discount Edgar/FA 6/13/23 BioLife4D Corp. S-1/A 6:1.8M M2 Compliance LLC/FA 5/12/23 BioLife4D Corp. S-1/A 3:1.8M M2 Compliance LLC/FA 5/08/23 BioLife4D Corp. S-1/A 3:1.6M M2 Compliance LLC/FA 5/01/23 BioLife4D Corp. S-1/A 2:1.5M M2 Compliance LLC/FA 4/27/23 BioLife4D Corp. 1-K 12/31/22 2:817K M2 Compliance LLC/FA 4/20/23 BioLife4D Corp. S-1/A 7:4.8M M2 Compliance LLC/FA 1/04/23 BioLife4D Corp. S-1/A 2:1.7M M2 Compliance LLC/FA 12/19/22 BioLife4D Corp. S-1/A 9:2.2M M2 Compliance LLC/FA 11/23/22 BioLife4D Corp. S-1/A 3:1.8M M2 Compliance LLC/FA 11/15/22 BioLife4D Corp. S-1/A 3:2M M2 Compliance LLC/FA 11/02/22 BioLife4D Corp. S-1/A 2:1.7M M2 Compliance LLC/FA 10/04/22 BioLife4D Corp. S-1/A 2:1.8M M2 Compliance LLC/FA 9/28/22 BioLife4D Corp. 1-SA 6/30/22 1:332K M2 Compliance LLC/FA 9/21/22 BioLife4D Corp. S-1/A 5:2.3M M2 Compliance LLC/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/21/22 BioLife4D Corp. S-1/A 4:1.7M M2 Compliance LLC/FA 6/03/22 BioLife4D Corp. S-1 50:6.2M M2 Compliance LLC/FA |